| AAEP | American Association of Equine Practitioners |
| APC | Antigen presenting cells |
| att | Attenuated |
| BGH | Bovine growth hormone |
| ca | Cold-adapted |
| CIV | Canine influenza virus |
| CMI | Cell mediated immunity |
| CTL | Cytotoxic T-lymphocytes |
| DIVA | Differentiation of infected from vaccinated animals |
| EI | Equine influenza |
| EID50 | 50% egg infective dose |
| EIV | Equine influenza virus |
| ELLA | Enzyme-linked lectin assay |
| ELISA | Enzyme-linked immunosorbent |
| ESP | Expert Surveillance Panel |
| FAO | Food and agriculture organization |
| FC-1 | Florida clade 1 |
| FC-2 | Florida clade 2 |
| FEI | Federation Equestre Internationale |
| HA | Hemagglutinin |
| HI | Hemagglutination inhibition |
| IAV | Influenza A virus |
| IBV | Influenza B virus |
| IFN | Interferon |
| ISCOM | Immunostimulating complexes |
| IFHA | International Federation for Horseracing Authorities |
| LAIV | Live attenuated influenza vaccine |
| MDCK | Madin–Darby Canine Kidney |
| MDV | Master donor virus |
| MHC | Major histocompatibility complex |
| MLV | Modified-live attenuated vaccines |
| M1 | Matrix protein 1 |
| M2 | Matrix protein 2 |
| NA | Neuraminidase |
| NAb | Neutralizing antibodies |
| NEP | Nuclear export protein |
| NCR | Noncoding regions |
| NP | Nucleoprotein |
| NS1 | Nonstructural protein 1 |
| OIE | Office International des Epizooties |
| PA | Polymerase acidic protein |
| PB1 | Polymerase basic protein 1 |
| PB2 | Polymerase basic protein 2 |
| PBMC | Peripheral blood mononuclear cells |
| RDE | Receptor-destroying-enzyme |
| SIV | Swine influenza virus |
| SRH | Single radial hemolysis |
| ts | Temperature sensitive |
| URT | Upper respiratory tract |
| USDA | US Department of Agriculture |
| WHO | World Health Organization |
| WT | Wild type |